160 related articles for article (PubMed ID: 9615746)
21. Antitumor activity of mono- and dimetallic transition metal carborane complexes of Ta, Fe, Co, Mo, or W.
Hall IH; Lackey CB; Kistler TD; Durham RW; Russell JM; Grimes RN
Anticancer Res; 2000; 20(4):2345-54. PubMed ID: 10953295
[TBL] [Abstract][Full Text] [Related]
22. Antitumor agents. 194. Synthesis and biological evaluations of 4-beta-mono-, -di-, and -trisubstituted aniline-4'-O-demethyl-podophyllotoxin and related compounds with improved pharmacological profiles.
Zhu XK; Guan J; Tachibana Y; Bastow KF; Cho SJ; Cheng HH; Cheng YC; Gurwith M; Lee KH
J Med Chem; 1999 Jul; 42(13):2441-6. PubMed ID: 10395485
[TBL] [Abstract][Full Text] [Related]
23. Cytotoxicity of 2-aldo- and 2-ketopyridine-N(4)-substituted thiosemicarbazones and mode of action in human Tmolt4 cells.
Hall IH; Barnes BJ; Rowell JE; Shaffer KA; Cho SE; West DX; Stark AM
Pharmazie; 2001 Aug; 56(8):648-53. PubMed ID: 11534344
[TBL] [Abstract][Full Text] [Related]
24. Antineoplastic activities of alpha-methyl-beta-alkylaminopropiophenone derivatives in tissue culture cells.
Huang Y; Hall IH
Anticancer Res; 1996; 16(6B):3589-95. PubMed ID: 9042226
[TBL] [Abstract][Full Text] [Related]
25. Cytotoxicity of a series of ferrocene-containing beta-diketones.
Swarts JC; Vosloo TG; Cronje SJ; Du Plessis WC; Van Rensburg CE; Kreft E; Van Lier JE
Anticancer Res; 2008; 28(5A):2781-4. PubMed ID: 19035310
[TBL] [Abstract][Full Text] [Related]
26. Cytotoxicity of ribo-and arabinoside boron nucleosides in tissue culture cells.
Sood A; Spielvogel BF; Powell WJ; Bastow KF; Miller MC; Hall IH
Anticancer Res; 1994; 14(4A):1483-8. PubMed ID: 7979174
[TBL] [Abstract][Full Text] [Related]
27. Mechanism of action of ferrocene derivatives on the catalytic activity of topoisomerase IIalpha and beta--distinct mode of action of two derivatives.
Sai Krishna AD; Panda G; Kondapi AK
Arch Biochem Biophys; 2005 Jun; 438(2):206-16. PubMed ID: 15907782
[TBL] [Abstract][Full Text] [Related]
28. Cytotoxicity of copper and cobalt complexes of furfural semicarbazone and thiosemicarbazone derivatives in murine and human tumor cell lines.
Hall IH; Lackey CB; Kistler TD; Durham RW; Jouad EM; Khan M; Thanh XD; Djebbar-Sid S; Benali-Baitich O; Bouet GM
Pharmazie; 2000 Dec; 55(12):937-41. PubMed ID: 11189872
[TBL] [Abstract][Full Text] [Related]
29. Migratory insertion in N-heterocyclic carbene-containing Fe carbonyl complexes: an experimental and theoretical study.
Llewellyn SA; Green ML; Green JC; Cowley AR
Dalton Trans; 2006 Jun; (21):2535-41. PubMed ID: 16718337
[TBL] [Abstract][Full Text] [Related]
30. The cytotoxicity of copper(II) complexes of 2-acetyl-pyridyl-4N-substituted thiosemicarbazones.
Miller MC; Stineman CN; Vance JR; West DX; Hall IH
Anticancer Res; 1998; 18(6A):4131-9. PubMed ID: 9891458
[TBL] [Abstract][Full Text] [Related]
31. Cytotoxicity of copper complexes of 2-furaldehyde oxime derivatives in murine and human tissue cultured cell lines.
Hall IH; Taylor K; Miller MC; Dothan X; Khan MA; Bouet FM
Anticancer Res; 1997; 17(4A):2411-8. PubMed ID: 9252656
[TBL] [Abstract][Full Text] [Related]
32. Enhanced antitumour activity of cyclopendadienyl-substituted metallocene dihalides in human breast and colon cancer cells.
Stachtea X; Karamanos N; Klouras N
Anticancer Res; 2009 Aug; 29(8):3227-31. PubMed ID: 19661339
[TBL] [Abstract][Full Text] [Related]
33. Tetranuclear complexes of [Fe(CO)2(C5H5)]+ with TCNX ligands (TCNX=TCNE, TCNQ, TCNB): intramolecular electron transfer alternatives in compounds (mu4-TCNX)[MLn]4.
Maity AN; Schwederski B; Sarkar B; Zális S; Fiedler J; Kar S; Lahiri GK; Duboc C; Grunert M; Gütlich P; Kaim W
Inorg Chem; 2007 Sep; 46(18):7312-20. PubMed ID: 17691765
[TBL] [Abstract][Full Text] [Related]
34. The synthesis of [FeRu(CO)2(mu-CO)2(eta-C5H5)(eta-C5Me5)] and convenient entries to its organometallic chemistry.
Dennett JN; Knox SA; Anderson KM; Charmant JP; Orpen AG
Dalton Trans; 2005 Jan; (1):63-73. PubMed ID: 15605148
[TBL] [Abstract][Full Text] [Related]
35. Structure-activity relationships for substituted bis(acridine-4-carboxamides): a new class of anticancer agents.
Gamage SA; Spicer JA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
J Med Chem; 1999 Jul; 42(13):2383-93. PubMed ID: 10395479
[TBL] [Abstract][Full Text] [Related]
36. Syntheses and X-ray crystal structures of alpha- and beta-[XeO2F][SbF6], [XeO2F][AsF6], [FO2XeFXeO2F][AsF6], and [XeF5][SbF6)].XeOF4 and computational studies of the XeO2F+ and FO2XeFXeO2F+ cations and related species.
Pointner BE; Suontamo RJ; Schrobilgen GJ
Inorg Chem; 2006 Feb; 45(4):1517-34. PubMed ID: 16471963
[TBL] [Abstract][Full Text] [Related]
37. Antitumor activity of ionic niobocene and molybdenocene complexes in high oxidation states.
Köpf-Maier P; Klapötke T
J Cancer Res Clin Oncol; 1992; 118(3):216-21. PubMed ID: 1548287
[TBL] [Abstract][Full Text] [Related]
38. Antineoplastic activities of alpha-, beta-, and gamma-alkylaminopropiophenone derivatives in mice and in murine and human tissue culture cells.
Huang Y; Hall IH
Anticancer Res; 1996; 16(2):597-604. PubMed ID: 8687103
[TBL] [Abstract][Full Text] [Related]
39. Novel antitumor indenoindole derivatives targeting DNA and topoisomerase II.
Bal C; Baldeyrou B; Moz F; Lansiaux A; Colson P; Kraus-Berthier L; Léonce S; Pierré A; Boussard MF; Rousseau A; Wierzbicki M; Bailly C
Biochem Pharmacol; 2004 Nov; 68(10):1911-22. PubMed ID: 15476662
[TBL] [Abstract][Full Text] [Related]
40. A study of the topoisomerase II activity in HIV-1 replication using the ferrocene derivatives as probes.
Kondapi AK; Satyanarayana N; Saikrishna AD
Arch Biochem Biophys; 2006 Jun; 450(2):123-32. PubMed ID: 16712776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
